Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RSV
Pharma
Pfizer, GSK RSV shots may raise Guillain-Barré risk: officials
A preliminary analysis found a potentially higher risk of Guillain-Barré syndrome following RSV vaccination in older adults.
Zoey Becker
Mar 4, 2024 11:46am
Moderna's COVID manufacturing cuts lead to layoffs
Mar 1, 2024 12:13pm
In year 2, Pfizer's RSV vax Abrysvo retains most of its efficacy
Feb 29, 2024 8:02am
AbbVie continues winning streak as DTC spend king
Feb 8, 2024 4:06am
Analysts tip label expansion to bolster GSK's hand in RSV fight
Feb 7, 2024 7:20am
GSK reports blockbuster sales for Arexvy in RSV race vs. Pfizer
Jan 31, 2024 9:50am